Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.

Volume: 169, Pages: 113623 - 113623
Published: Aug 28, 2019
Abstract
Cannabinoid receptors type 1 (CB1) and type 2 (CB2) are promising targets for a number of diseases, including obesity, neuropathic pain, and multiple sclerosis, among others. Upon ligand-mediated activation of these receptors, multiple receptor conformations could be stabilized, resulting in a complex pattern of possible intracellular effects. Although numerous compounds have been developed and widely used to target cannabinoid receptors, their...
Paper Details
Title
Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists.
Published Date
Aug 28, 2019
Volume
169
Pages
113623 - 113623
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.